eicosapentaenoic acid ethyl ester and vericiguat

eicosapentaenoic acid ethyl ester has been researched along with vericiguat in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Agarwala, A; Al Rifai, M; Gulati, M; Jia, X; Liu, J; Virani, SS1

Reviews

1 review(s) available for eicosapentaenoic acid ethyl ester and vericiguat

ArticleYear
Highlights of Studies in Cardiovascular Disease Prevention Presented at the 2020 American College of Cardiology Annual Scientific Session.
    Current atherosclerosis reports, 2020, 06-18, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Child; Cholesterol, LDL; Denervation; Eicosapentaenoic Acid; Electronic Nicotine Delivery Systems; Female; Heart Failure; Heterocyclic Compounds, 2-Ring; Humans; Hyperlipoproteinemia Type II; Hypertension; Kidney; Male; Middle Aged; Pyrimidines; Randomized Controlled Trials as Topic; Smoking Cessation; United States; Young Adult

2020